1. Adelaide Research & Scholarship

Search


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 11181-11190 of 14621 (Search time: 0.012 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2016Caffeine toxicity in forensic practice: possible effects and under-appreciated sourcesMusgrave, I.; Farrington, R.; Hoban, C.; Byard, R.
2016Nocturia, other lower urinary tract symptoms and sleep dysfunction in a community-dwelling cohort of menMartin, S.A.; Appleton, S.L.; Adams, R.J.; Taylor, A.W.; Catcheside, P.G.; Vakulin, A.; McEvoy, R.D.; Antic, N.A.; Wittert, G.A.
2017Using imaging to identify the high-risk diabetic patient: are we any closer?Nicholls, S.; Andrews, J.; Psaltis, P.
2000Peritoneal defenses against infection: Winning the battle but losing the war?Faull, R.
2014Rapid increases in infant adiposity and overweight/obesity in childhood are associated with higher central and brachial blood pressure in early adulthoodHowe, L.D.; Chaturvedi, N.; Lawlor, D.A.; Ferreira, D.L.S.; Fraser, A.; Davey Smith, G.; Tilling, K.; Hughes, A.D.
2010Stability of plasma creatinine concentrations in acute complex long-stay admissions to a general medical serviceSiriwardane, D.; Woodman, R.; Hakendorf, P.; Martin, J.; White, G.; Ben-Tovim, D.; Thompson, C.
2015Autophagy in malignant transformation and cancer progressionGalluzzi, L.; Pietrocola, F.; Bravo-San Pedro, J.; Amaravadi, R.; Baehrecke, E.; Cecconi, F.; Codogno, P.; Debnath, J.; Gewirtz, D.; Karantza, V.; Kimmelman, A.; Kumar, S.; Levine, B.; Maiuri, M.; Martin, S.; Penninger, J.; Piacentini, M.; Rubinsztein, D.; Simon, H.; Simonsen, A.; et al.
2015Ecdysone-mediated programmed cell death in DrosophilaNicolson, S.; Denton, D.; Kumar, S.
2012Aberrant STAT5 and PI3K/mTOR pathway signaling occurs in human CRLF2-rearranged B-precursor acute lymphoblastic leukemiaTasian, S.; Doral, M.; Borowitz, M.; Wood, B.; Chen, I.-M.; Harvey, R.; Gastier-Foster, J.; Willman, C.; Hunger, S.; Mullighan, C.; Loh, M.
2014Outcomes of children with BCR-ABL1-like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual diseaseRoberts, K.; Pei, D.; Campana, D.; Payne-Turner, D.; Li, Y.; Cheng, C.; Sandlund, J.; Jeha, S.; Easton, J.; Becksfort, J.; Zhang, J.; Coustan-Smith, E.; Raimondi, S.; Leung, W.; Relling, M.; Evans, W.; Downing, J.; Mullighan, C.; Pui, C.

Discover